Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.125 USD | -1.32% | -26.95% | +65.44% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.44% | 10.57M | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.04% | 21.66B | |
-18.35% | 20.77B | |
-8.61% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- IMNN Stock
- News Imunon, Inc.
- Celsion : to Raise $35 Million in Registered Direct Offering of Common Stock